Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Microbial Resource Management Health NV (Mrm Health) has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This single active matter is being reviewed by 1 distinct examiner in 1 distinct art unit, which points to a very focused prosecution strategy. The company's current success at the USPTO is entirely dependent on the resolution of this 1 pending office action within the life sciences sector.
The busiest examiner, CRUM, MARY ABOU NADER, is responsible for the 1 busiest examiner pending office action. Since there is only 1 pending office action in the entire portfolio, CRUM, MARY ABOU NADER is the only individual the applicant must interact with for their current filings. This concentration in 1 distinct art unit and under 1 distinct examiner allows the applicant to focus their resources on a single set of technical and legal arguments tailored to this specific examiner's perspective.
In the Biotechnology & Pharmaceuticals field, the involvement of only 1 distinct examiner can be an advantage for maintaining consistency in claim interpretation. The practitioner should prioritize understanding the specific examination style of CRUM, MARY ABOU NADER to move the 1 pending office action toward allowance. The lack of other pending matters means that the company's immediate patenting goals are tied exclusively to the 1 busiest examiner pending office action currently under review in the single art unit.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRUM, MARY ABOU NADER | 1 | 40.4% | +65.0% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17386266 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | CRUM, MARY ABOU NADER | — |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17386266 | USE OF MICROBIAL COMMUNITIES FOR HUMAN AND ANIMAL HEALTH | CRUM, MARY ABOU NADER | 1657 | §103Other | Final Rejection | — | Pending | Jul 27, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial